| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S1074-7613(00)00011-X |
| P698 | PubMed publication ID | 10933398 |
| P2093 | author name string | C E Rudd | |
| T Nguyen | |||
| C Lloyd | |||
| J C Gutierrez-Ramos | |||
| M Gosselin | |||
| H Schneider | |||
| S Manning | |||
| J Tian | |||
| A J Coyle | |||
| J A Gonzalo | |||
| T Delaney | |||
| L R Owen | |||
| S Lehar | |||
| T Burwell | |||
| P2860 | cites work | ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28 | Q22001503 |
| T-cell antigen CD28 interacts with the lipid kinase phosphatidylinositol 3-kinase by a cytoplasmic Tyr(P)-Met-Xaa-Met motif | Q24310233 | ||
| Stimulation of CD28 triggers an association between CD28 and phosphatidylinositol 3-kinase in Jurkat T cells | Q24680080 | ||
| T-cell co-stimulation through B7RP-1 and ICOS | Q28141589 | ||
| CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones | Q28209894 | ||
| CTLA-4 can function as a negative regulator of T cell activation | Q28235866 | ||
| Enhancement of antitumor immunity by CTLA-4 blockade | Q28275730 | ||
| Interleukin-13: central mediator of allergic asthma | Q28291712 | ||
| T cell antigen CD28 binds to the GRB-2/SOS complex, regulators of p21ras | Q28300793 | ||
| Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4 | Q29619280 | ||
| B7h, a novel costimulatory homolog of B7.1 and B7.2, is induced by TNFalpha | Q30807749 | ||
| Long-term inhibition of murine experimental autoimmune encephalomyelitis using CTLA-4-Fc supports a key role for CD28 costimulation. | Q34224070 | ||
| Immunosuppression in vivo by a soluble form of the CTLA-4 T cell activation molecule | Q34298838 | ||
| A two-step, two-signal model for the primary activation of precursor helper T cells | Q34797521 | ||
| CD28-mediated costimulation of interleukin 2 (IL-2) production plays a critical role in T cell priming for IL-4 and interferon gamma production | Q36362675 | ||
| CD28-B7 blockade after alloantigenic challenge in vivo inhibits Th1 cytokines but spares Th2. | Q36364843 | ||
| Limited role of CD28-mediated signals in T helper subset differentiation | Q36367295 | ||
| TRANCE, a tumor necrosis factor family member critical for CD40 ligand-independent T helper cell activation | Q36368029 | ||
| CC chemokine receptor (CCR)3/eotaxin is followed by CCR4/monocyte-derived chemokine in mediating pulmonary T helper lymphocyte type 2 recruitment after serial antigen challenge in vivo | Q36375742 | ||
| Induction of airway mucus production By T helper 2 (Th2) cells: a critical role for interleukin 4 in cell recruitment but not mucus production | Q36380917 | ||
| Cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) regulates the unfolding of autoimmune diabetes | Q36400199 | ||
| CD28-independent induction of T helper cells and immunoglobulin class switches requires costimulation by the heat-stable antigen. | Q36400564 | ||
| H. polygyrus: B7-independence of the secondary type 2 response | Q39436438 | ||
| OX40-deficient mice are defective in Th cell proliferation but are competent in generating B cell and CTL Responses after virus infection | Q40907799 | ||
| Costimulation through B7-2 (CD86) is required for the induction of a lung mucosal T helper cell 2 (TH2) immune response and altered airway responsiveness | Q41843358 | ||
| Inducible costimulator protein (ICOS) controls T helper cell subset polarization after virus and parasite infection | Q42753302 | ||
| Ox40-ligand has a critical costimulatory role in dendritic cell:T cell interactions | Q42806821 | ||
| Crucial role of the interleukin 1 receptor family member T1/ST2 in T helper cell type 2-mediated lung mucosal immune responses. | Q42947124 | ||
| Functional responses and costimulator dependence of memory CD4+ T cells. | Q52030310 | ||
| CTLA4-Ig inhibits optimal T helper 2 cell development but not protective immunity or memory response to Nippostrongylus brasiliensis. | Q52035494 | ||
| Induction of peripheral T cell tolerance in vivo requires CTLA-4 engagement. | Q54308518 | ||
| CTLA4Ig inhibits airway eosinophilia and hyperresponsiveness by regulating the development of Th1/Th2 subsets in a murine model of asthma | Q56907759 | ||
| B7-1 and B7-2 have overlapping, critical roles in immunoglobulin class switching and germinal center formation | Q56908531 | ||
| A cell culture model for T lymphocyte clonal anergy | Q67299314 | ||
| The role of CCR7 in TH1 and TH2 cell localization and delivery of B cell help in vivo | Q73257315 | ||
| Noninvasive measurement of airway responsiveness in allergic mice using barometric plethysmography | Q73730758 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 95-105 | |
| P577 | publication date | 2000-07-01 | |
| P1433 | published in | Immunity | Q6005457 |
| P1476 | title | The CD28-related molecule ICOS is required for effective T cell-dependent immune responses | |
| P478 | volume | 13 |
| Q54977058 | "Immune TOR-opathies," a Novel Disease Entity in Clinical Immunology. |
| Q38598814 | 14 Years after Discovery: Clinical Follow-up on 15 Patients with Inducible Co-Stimulator Deficiency |
| Q37026428 | A TRAF-like motif of the inducible costimulator ICOS controls development of germinal center TFH cells via the kinase TBK1. |
| Q44476352 | A critical role for ICOS co-stimulation in immune containment of pulmonary influenza virus infection |
| Q95319497 | A guide to cancer immunotherapy: from T cell basic science to clinical practice |
| Q36236577 | A pilot trial targeting the ICOS-ICOS-L pathway in nonhuman primate kidney transplantation. |
| Q28610409 | A single amino acid alteration in cytoplasmic domain determines IL-2 promoter activation by ligation of CD28 but not inducible costimulator (ICOS) |
| Q92150338 | AP-1 Transcription Factors as Regulators of Immune Responses in Cancer |
| Q28511741 | AP-1 is involved in ICOS gene expression downstream of TCR/CD28 and cytokine receptor signaling |
| Q35848468 | Absence of inducible costimulator on alloreactive T cells reduces graft versus host disease and induces Th2 deviation |
| Q49030635 | Accelerated Airway Dendritic Cell Maturation, Trafficking, and Elimination in a Mouse Model of Asthma |
| Q34517906 | Activation and inhibition of lymphocytes by costimulation |
| Q58746553 | Akt2 Regulates the Differentiation and Function of NKT17 Cells via FoxO-1-ICOS Axis |
| Q34786974 | Allergy immunotherapy and inhibition of Th2 immune responses: a sufficient strategy? |
| Q34340571 | Altered T cell signalling in ageing |
| Q47349199 | Analysis of the CTLA-4, CD28, and inducible costimulator (ICOS) genes in autoimmune thyroid disease |
| Q37115223 | Anti-CTLA-4 therapy results in higher CD4+ICOShi T cell frequency and IFN-gamma levels in both nonmalignant and malignant prostate tissues |
| Q49662013 | Anti-Inducible Costimulator Monoclonal Antibody Treatment of Canine Chronic Graft-versus-Host Disease |
| Q34534351 | Anti-chlamydial Th17 responses are controlled by the inducible costimulator partially through phosphoinositide 3-kinase signaling |
| Q30486421 | Antigen-independent adhesion and cell spreading by inducible costimulator engagement inhibits T cell migration in a PI-3K-dependent manner |
| Q24302386 | Antigen-specific regulatory T cells develop via the ICOS-ICOS-ligand pathway and inhibit allergen-induced airway hyperreactivity |
| Q56897469 | Association of Hashimoto's thyroiditis with cytotoxic T lymphocyte-associated antigen-4 (CTLA-4) and inducible co-stimulator (ICOS) genes in a Kuwaiti population |
| Q34765268 | Asthma: an epidemic of dysregulated immunity |
| Q42554635 | B and T lymphocyte attenuator regulates T cell survival in the lung |
| Q34169250 | B7 costimulation and intracellular indoleamine-2,3-dioxygenase (IDO) expression in peripheral blood of healthy pregnant and non-pregnant women. |
| Q38129635 | B7 family checkpoint regulators in immune regulation and disease |
| Q36185034 | B7 family molecules as regulators of the maternal immune system in pregnancy |
| Q35607509 | B7RP-1-ICOS interactions are required for optimal infection-induced expansion of CD4+ Th1 and Th2 responses |
| Q33715667 | B7h is required for T cell activation, differentiation, and effector function |
| Q34300038 | B7h-expressing dendritic cells and plasma B cells mediate distinct outcomes of ICOS costimulation in T cell-dependent antibody responses |
| Q38338446 | Biased binding of class IA phosphatidyl inositol 3-kinase subunits to inducible costimulator (CD278). |
| Q92992303 | Blockade of CTLA-4 and PD-1 Enhances Adoptive T-cell Therapy Efficacy in an ICOS-Mediated Manner |
| Q36251308 | Bone marrow transplantation and approaches to avoid graft-versus-host disease (GVHD). |
| Q37356373 | CD28 and ICOS play complementary non-overlapping roles in the development of Th2 immunity in vivo. |
| Q73208123 | CD28 costimulation is critical for experimental allergic asthma in HLA-DQ8 transgenic mice |
| Q47645432 | CD28/CTLA4 double deficient mice demonstrate crucial role for B7 co-stimulation in the induction of allergic lower airways disease |
| Q41063787 | CD3+ICOS+ T cells show differences in the synthesis of nitric oxide, IFN-γ, and IL-10 in patients with pulmonary tuberculosis or in healthy household contacts. |
| Q37069249 | CD86 has sustained costimulatory effects on CD8 T cells |
| Q42370428 | Casein kinase 2 is a critical determinant of the balance of Th17 and Treg cell differentiation |
| Q24645109 | Constitutive and inducible expression of b7 family of ligands by human airway epithelial cells |
| Q36371140 | Constitutive expression of the B7h ligand for inducible costimulator on naive B cells is extinguished after activation by distinct B cell receptor and interleukin 4 receptor-mediated pathways and can be rescued by CD40 signaling |
| Q73588963 | Costimulation through the inducible costimulator ligand is essential for both T helper and B cell functions in T cell-dependent B cell responses |
| Q36026037 | Costimulation: critical pathways in the immunologic regulation of asthma |
| Q35733851 | Costimulatory molecules and T-cell-B-cell interactions |
| Q34187594 | Costimulatory pathways in transplantation |
| Q34700403 | Cytokine memory of T helper lymphocytes |
| Q34638212 | Differences in allergen-induced T cell activation between allergic asthma and rhinitis: Role of CD28, ICOS and CTLA-4 |
| Q35105753 | Disruption of the ICOS-B7RP-1 costimulatory pathway leads to enhanced hepatic immunopathology and increased gamma interferon production by CD4 T cells in murine schistosomiasis |
| Q38357683 | Down-regulation of inducible co-stimulator (ICOS) by intravitreal injection of small interfering RNA (siRNA) plasmid suppresses ongoing experimental autoimmune uveoretinitis in rats |
| Q37098142 | Early pediatric atopic dermatitis shows only a cutaneous lymphocyte antigen (CLA)(+) TH2/TH1 cell imbalance, whereas adults acquire CLA(+) TH22/TC22 cell subsets |
| Q35789338 | Effector functions of donor-reactive CD8 memory T cells are dependent on ICOS induced during division in cardiac grafts |
| Q39325384 | Effects of ICOSLG expressed in mouse hematological neoplasm cell lines in the GVL reaction |
| Q38160477 | Emerging Co-signaling Networks in T Cell Immune Regulation |
| Q24796946 | Emerging mechanisms of immune regulation: the extended B7 family and regulatory T cells |
| Q81704177 | Endothelial inducible costimulator ligand expression is increased during human cardiac allograft rejection and regulates endothelial cell-dependent allo-activation of CD8+ T cells in vitro |
| Q37446021 | Enhanced inducible costimulator ligand (ICOS-L) expression on dendritic cells in interleukin-10 deficiency and its impact on T-cell subsets in respiratory tract infection |
| Q51672373 | Evaluation of inducible costimulator/B7-related protein-1 as a therapeutic target in a murine model of allergic airway inflammation. |
| Q38070582 | Experimental advances in understanding allergic airway inflammation |
| Q53625991 | Expression level of costimulatory receptor ICOS is critical for determining the polarization of helper T cell function. |
| Q42087961 | Expression of ICOS in vivo defines CD4+ effector T cells with high inflammatory potential and a strong bias for secretion of interleukin 10. |
| Q28198548 | Expression of the Costimulatory Molecule B7-H2 (Inducible Costimulator Ligand) by Human Airway Epithelial Cells |
| Q79769520 | Follicular B helper T cell activity is confined to CXCR5(hi)ICOS(hi) CD4 T cells and is independent of CD57 expression |
| Q24676570 | Follicular B helper T cells express CXC chemokine receptor 5, localize to B cell follicles, and support immunoglobulin production |
| Q34097548 | Follicular homing T helper (Th) cells and the Th1/Th2 paradigm |
| Q64376358 | Further study of anti-ICOS immunotherapy for rat cardiac allograft rejection |
| Q36879648 | Genetic defects in common variable immunodeficiency |
| Q28215982 | Genetics of type 1 diabetes mellitus |
| Q34015403 | Germinal center B cell depletion diminishes CD4+ follicular T helper cells in autoimmune mice |
| Q37418386 | Histocompatibility methods. |
| Q28072305 | ICOS Co-Stimulation: Friend or Foe? |
| Q62734291 | ICOS and B7 costimulatory molecule expression identifies activated cellular subsets in rheumatoid arthritis |
| Q28187985 | ICOS co-stimulatory receptor is essential for T-cell activation and function |
| Q79169969 | ICOS cooperates with CD28, IL-2, and IFN-gamma and modulates activation of human naïve CD4+ T cells |
| Q35062102 | ICOS costimulation in inflammatory bowel disease. |
| Q24291377 | ICOS costimulation: It's not just for TH2 cells anymore |
| Q24299856 | ICOS expression by activated human Th cells is enhanced by IL-12 and IL-23: increased ICOS expression enhances the effector function of both Th1 and Th2 cells |
| Q28589705 | ICOS is critical for CD40-mediated antibody class switching |
| Q56905108 | ICOS is critical for T helper cell-mediated lung mucosal inflammatory responses |
| Q28594859 | ICOS is essential for effective T-helper-cell responses |
| Q55222376 | ICOS signal facilitates Foxp3 transcription to favor suppressive function of regulatory T cells. |
| Q92915743 | ICOS-deficient and ICOS YF mutant mice fail to control Toxoplasma gondii infection of the brain |
| Q24296273 | ICOS-ligand, expressed on human endothelial cells, costimulates Th1 and Th2 cytokine secretion by memory CD4+ T cells |
| Q35196224 | ICOS:ICOS-ligand interaction is required for type 2 innate lymphoid cell function, homeostasis, and induction of airway hyperreactivity. |
| Q35208767 | Immune regulation by novel costimulatory molecules |
| Q36993451 | Immunological decision-making: how does the immune system decide to mount a helper T-cell response? |
| Q35611780 | Immunology of B7-H1 and its roles in human diseases |
| Q91816563 | Immunomodulatory Bonds of the Partnership between Dendritic Cells and T Cells |
| Q42440317 | Impaired germinal center formation and recall T-cell–dependent immune responses in mice lacking the costimulatory ligand B7-H2 |
| Q43655794 | Importance of ICOS-B7RP-1 costimulation in acute and chronic allograft rejection |
| Q47736332 | Importance of the inducible costimulator molecule for the induction of allergic immune responses and its decreased expression on T helper cells after venom immunotherapy |
| Q37238638 | In vivo and in vitro adjuvant activities of the B subunit of Type IIb heat-labile enterotoxin (LT-IIb-B5) from Escherichia coli. |
| Q36403375 | In vivo depletion of lung CD11c+ dendritic cells during allergen challenge abrogates the characteristic features of asthma |
| Q36811763 | Inducible T-cell co-stimulator ligand (ICOSL) blockade leads to selective inhibition of anti-KLH IgG responses in subjects with systemic lupus erythematosus |
| Q54609816 | Inducible co-stimulator (ICOS) is upregulated in experimental autoimmune uveoretinitis. |
| Q35527988 | Inducible costimulator controls migration of T cells to the lungs via down-regulation of CCR7 and CD62L |
| Q33514875 | Inducible costimulator expression regulates the magnitude of Th2-mediated airway inflammation by regulating the number of Th2 cells |
| Q33896026 | Inducible costimulator is required for type 2 antibody isotype switching but not T helper cell type 2 responses in chronic nematode infection |
| Q44972273 | Inducible-costimulator-mediated suppression of human immunodeficiency virus type 1 replication in CD4(+) T lymphocytes |
| Q33605239 | Induction of B7-H1 and B7-DC expression on airway epithelial cells by the Toll-like receptor 3 agonist double-stranded RNA and human rhinovirus infection: In vivo and in vitro studies |
| Q46061458 | Induction of T helper type 1-like regulatory cells that express Foxp3 and protect against airway hyper-reactivity |
| Q44419299 | Induction of immunologic tolerance to cardiac allograft by simultaneous blockade of inducible co-stimulator and cytotoxic T-lymphocyte antigen 4 pathway1 |
| Q75200122 | Informatics and the immune system: the expanding IL-1 and B7 protein families |
| Q35670810 | Inhibition of Donor-Reactive CD8+ T Cell Responses by Selective CD28 Blockade Is Independent of Reduced ICOS Expression |
| Q24805693 | Inhibitors of mitogen-activated protein kinases differentially regulate costimulated T cell cytokine production and mouse airway eosinophilia. |
| Q47782299 | Interleukin-13-dependent expression of matrix metalloproteinase-12 is required for the development of airway eosinophilia in mice |
| Q34992448 | Interplay between T helper type 1 and type 2 cytokines and soluble major histocompatibility complex molecules: a paradigm in pregnancy |
| Q52955868 | Involvement of ICOS-B7RP-1 costimulatory pathway in the regulation of immune responses to Leishmania major and Nippostrongylus brasiliensis infections |
| Q59005464 | It takes more than two to tango |
| Q41191163 | Lack of association between sCTLA-4 levels in human plasma and common CTLA-4 polymorphisms |
| Q24674583 | Ligand binding sites of inducible costimulator and high avidity mutants with improved function |
| Q42149294 | Loss of Immune Tolerance Is Controlled by ICOS in Sle1 Mice. |
| Q36851026 | Mammaglobin-A cDNA vaccination of breast cancer patients induces antigen-specific cytotoxic CD4+ICOShi T cells |
| Q28208475 | Microanatomical localization of PD-1 in human tonsils |
| Q36494214 | Modification of accessory molecule signaling |
| Q42637857 | Molecular cloning and characterization of canine ICOS. |
| Q56903870 | More negative feedback? |
| Q34212495 | Mouse models of allergic airway disease |
| Q34987302 | New regulatory co-receptors: inducible co-stimulator and PD-1. |
| Q55383705 | Next generation immune-checkpoints for cancer therapy. |
| Q34415795 | Nitric oxide preferentially induces type 1 T cell differentiation by selectively up-regulating IL-12 receptor beta 2 expression via cGMP |
| Q36371325 | OX40 (CD134) controls memory T helper 2 cells that drive lung inflammation |
| Q39598751 | OX40 complexes with phosphoinositide 3-kinase and protein kinase B (PKB) to augment TCR-dependent PKB signaling |
| Q82305700 | OX40 interactions in gastrointestinal nematode infection |
| Q91816062 | Orchestration between ILC2s and Th2 cells in shaping type 2 immune responses |
| Q28609463 | PIP3 pathway in regulatory T cells and autoimmunity |
| Q35053704 | Phosphatidylinositol 3-kinase-independent signaling pathways contribute to ICOS-mediated T cell costimulation in acute graft-versus-host disease in mice |
| Q92852963 | Programmed Cell Death-1 Receptor (PD-1)-Mediated Regulation of Innate Lymphoid Cells |
| Q53912899 | Regulation of immune and autoimmune responses by ICOS. |
| Q36592988 | Retrogenic ICOS Expression Increases Differentiation of KLRG-1hiCD127loCD8+ T Cells during Listeria Infection and Diminishes Recall Responses |
| Q54732704 | Reverse signaling using an inducible costimulator to enhance immunogenic function of dendritic cells. |
| Q34243622 | Role of dendritic cells and Th2 lymphocytes in asthma: lessons from eosinophilic airway inflammation in the mouse |
| Q36622372 | Role of nitric oxide in the regulation of T cell functions |
| Q34102463 | SF20/IL-25, a novel bone marrow stroma-derived growth factor that binds to mouse thymic shared antigen-1 and supports lymphoid cell proliferation |
| Q37871903 | Searching for "signal 2": costimulation requirements of γδ T cells. |
| Q64057605 | Selecting costimulatory domains for chimeric antigen receptors: functional and clinical considerations |
| Q36861565 | Semaphorin 6D regulates the late phase of CD4+ T cell primary immune responses |
| Q33182376 | Separable effector T cell populations specialized for B cell help or tissue inflammation |
| Q44788673 | Simultaneous blockade of co-stimulatory signals, CD28 and ICOS, induced a stable tolerance in rat heart transplantation |
| Q37073896 | Suppression of T cell costimulator ICOS by Delta9-tetrahydrocannabinol |
| Q28755503 | T cell Ig and mucin domain-1-mediated T cell activation requires recruitment and activation of phosphoinositide 3-kinase |
| Q24658051 | T cell activation |
| Q56905450 | T cell activation: you can't get good help |
| Q37923993 | T cell costimulation and coinhibition: genetics and disease. |
| Q34296494 | T cell effector subsets: extending the Th1/Th2 paradigm |
| Q33417942 | T cell immune abnormalities in immune thrombocytopenia |
| Q77797891 | T(H)1 and T(H)2 cells: a historical perspective |
| Q54121475 | T-Cell-Specific Loss of the PI-3-Kinase p110α Catalytic Subunit Results in Enhanced Cytokine Production and Antitumor Response. |
| Q35803977 | T-cell activation and transplantation tolerance |
| Q36972497 | T-cell co-stimulatory pathways in autoimmunity |
| Q35583511 | T-cell costimulatory pathways in allograft rejection and tolerance |
| Q33854453 | Targeting the Human T-Cell Inducible COStimulator Molecule with a Monoclonal Antibody Prevents Graft-vs-Host Disease and Preserves Graft vs Leukemia in a Xenograft Murine Model |
| Q60015909 | Targeting the ICOS/ICOS-L pathway in a mouse model of established allergic asthma disrupts T follicular helper cell responses and ameliorates disease |
| Q34319955 | Th1- and Th2-cell commitment during infectious disease: asymmetry in divergent pathways |
| Q34332637 | Th1/Th2 effector choice in parasitic infection: decision making by committee |
| Q28594992 | The B7 family member B7-H3 preferentially down-regulates T helper type 1-mediated immune responses |
| Q34575331 | The B7-CD28 superfamily |
| Q36443069 | The Costimulatory Molecule ICOS Regulates Host Th1 and Follicular Th Cell Differentiation in Response to Plasmodium chabaudi chabaudi AS Infection. |
| Q93055420 | The ICOSL Expression Predicts Better Prognosis for Nasopharyngeal Carcinoma via Enhancing Oncoimmunity |
| Q58561801 | The Infiltration of ICOS Cells in Nasopharyngeal Carcinoma is Beneficial for Improved Prognosis |
| Q28594893 | The Junctional Adhesion Molecule JAML Is a Costimulatory Receptor for Epithelial γδ T Cell Activation |
| Q35998858 | The balance of immune responses: costimulation verse coinhibition |
| Q37586853 | The blockade of T-cell co-stimulation as a therapeutic stratagem for immunosuppression: Focus on belatacept. |
| Q37012600 | The clinical impact of ICOS signal in colorectal cancer patients |
| Q35605705 | The contribution of immune regulatory and thyroid specific genes to the etiology of Graves' and Hashimoto's diseases |
| Q36844711 | The contribution of immunology to the rational design of novel antibacterial vaccines |
| Q48827709 | The costimulatory molecule ICOS plays an important role in the immunopathogenesis of EAE. |
| Q24655751 | The costimulatory molecule ICOS regulates the expression of c-Maf and IL-21 in the development of follicular T helper cells and TH-17 cells |
| Q34165325 | The expanding B7 superfamily: increasing complexity in costimulatory signals regulating T cell function |
| Q34198913 | The expanding world of co-stimulation: the two-signal model revisited |
| Q37108443 | The great balancing act: regulation and fate of antiviral T-cell interactions |
| Q35581696 | The immunological synapse for B-cell memory: the role of the ICOS and its ligand for the longevity of humoral immunity |
| Q38085577 | The nature of activatory and tolerogenic dendritic cell-derived signal II. |
| Q39664121 | The regulation of T‐cell cytokine production by ICOS–B7H2 interactions at the human fetomaternal interface |
| Q34612568 | The right place at the right time: novel B7 family members regulate effector T cell responses |
| Q53666361 | The role of B7 family costimulatory molecules and indoleamine 2,3-dioxygenase in primary Sjögren's syndrome and systemic sclerosis. |
| Q35681790 | The role of ICOS and other costimulatory molecules in allergy and asthma |
| Q39785791 | The role of the ICOS-B7h T cell costimulatory pathway in transplantation immunity. |
| Q35772868 | The roles of the new negative T cell costimulatory pathways in regulating autoimmunity |
| Q34269503 | Tim-3 inhibits T helper type 1-mediated auto- and alloimmune responses and promotes immunological tolerance. |
| Q47815861 | Transcriptional regulation of th2 differentiation by inducible costimulator |
| Q90318157 | Transmembrane domain-mediated Lck association underlies bystander and costimulatory ICOS signaling |
| Q28189055 | Unifying concepts in CD28, ICOS and CTLA4 co-receptor signalling |
| Q33951453 | Upregulation of ICOS on CD43+ CD4+ murine small intestinal intraepithelial lymphocytes during acute reovirus infection |
| Q28584882 | VSIG4, a B7 family-related protein, is a negative regulator of T cell activation |
| Q33872168 | Yin-Yang of costimulation: crucial controls of immune tolerance and function |
| Q89965819 | c-MAF, a Swiss Army Knife for Tolerance in Lymphocytes |
Search more.